Kolexia
Hofman Veronique
Anatomie et cytologie
Hôpital Pasteur
Nice, France
234 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du poumon Carcinome pulmonaire non à petites cellules Carcinome pulmonaire à petites cellules Carcinomes Cellules tumorales circulantes Mélanome Adénocarcinome Adénocarcinome pulmonaire Métastase tumorale

Industries

BMS
3 collaboration(s)
Dernière en 2022
MSD
2 collaboration(s)
Dernière en 2021
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

AIR: Circulating Tumor Cells and Early Diagnosis of Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease
Essai Clinique (CHU Nice)   05 février 2024
Activation of the P2RX7/IL-18 pathway in immune cells attenuates lung fibrosis.
eLife   01 février 2024
Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes.
Cancer cell   24 janvier 2024
c-Met immunohistochemistry as reflex test at diagnosis for non-small cell lung cancer: a real-world experience from a monocentric case series.
Journal of clinical pathology   08 novembre 2023
Usefulness of an RNA extraction-free test for the multiplexed detection of , , and Gene Fusions in Real Life FFPE Specimens of Non-Small Cell Lung Cancers.
Expert review of molecular diagnostics   31 octobre 2023
Current challenges and practical aspects of molecular pathology for non-small cell lung cancers.
Virchows Archiv : an international journal of pathology   06 octobre 2023
Programmed death ligand 1 immunohistochemistry in non-small cell lung carcinoma.
Journal of thoracic disease   05 octobre 2023
1230P hPG80 (circulating progastrin) is a new blood-based biomarker for diagnosis of early-stage non-small cell lung cancers
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer.
Journal of visualized experiments : JoVE   08 septembre 2023
MelBase: Constitution of a National Cohort of Patients With Metastatic Melanoma Resectable Stage II or Stage III or IV or Unresectable Primary With the Objective of Setting up Epidemiological Monitoring and Clinico-biological Database, MELBASE
Essai Clinique (Assistance publique – Hôpitaux de Paris)   07 juillet 2023